Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | IDO1 | P14902 | 1/20 | 0.45 |
| ▸ | METAP2 | P50579 | 1/20 | 0.45 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.45 |
| ▸ | RAB9A | P51151 | 2/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.42 |
| ▸ | MEN1 | O00255 | 3/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.42 |
| ▸ | AKT1 | P31749 | 1/20 | 0.41 |
| ▸ | AKT2 | P31751 | 1/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | ATM | Q13315 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.37 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL842040 | 1.00 | CYP1A2 (0.47) | CYP1A2IDO1METAP2KEAP1RAB9A | |
| SCHEMBL9438 | 0.98 | CYP1A2 (0.48) | CYP1A2IDO1METAP2KEAP1RAB9A | |
| SCHEMBL30636164 | 0.95 | CYP1A2 (0.47) | CYP1A2IDO1METAP2KEAP1RAB9A | |
| Phosphine SCHEMBL28114703 | 0.95 | CYP1A2 (0.47) | CYP1A2IDO1METAP2KEAP1RAB9A | |
| SCHEMBL28309054 | 0.95 | CYP1A2 (0.47) | CYP1A2IDO1METAP2KEAP1RAB9A | |
| SCHEMBL31519384 | 0.95 | CYP1A2 (0.47) | CYP1A2IDO1METAP2KEAP1RAB9A | |
| Ammonia Solution, Strong SCHEMBL29843017 | 0.95 | CYP1A2 (0.47) | CYP1A2IDO1METAP2KEAP1RAB9A | |
| SCHEMBL16800868 | 0.93 | CYP1A2 (0.45) | CYP1A2IDO1METAP2KEAP1RAB9A | |
| Bicarbonate SCHEMBL7945138 | 0.89 | TP53 (0.47) | CYP1A2IDO1METAP2KEAP1RAB9A | |
| Piperazine SCHEMBL28211307 | 0.87 | CYP1A2 (0.41) | CYP1A2IDO1METAP2KEAP1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 115 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3846212-B1 | PIXEL DEFINITION STRUCTURE, DISPLAY PANEL AND PREPARATION METHOD THEREFOR, AND DISPLAY APPARATUS | BOE TECHNOLOGY GROUP CO LTD (CN) | 2025-05-21 | — | — | EP | disclosed |
| CN-116606640-A | Iridium metal organic compound covalent functionalized graphene oxide ternary nano hybrid material and preparation method thereof | 江苏大学 | 2023-08-18 | — | — | CN | disclosed |
| CN-113851595-B | Organic electroluminescent device and display device | 京东方科技集团股份有限公司 | 2023-05-23 | — | — | CN | disclosed |
| CN-115295561-A | Display panel, display device and manufacturing method | 武汉天马微电子有限公司 | 2022-11-04 | — | — | CN | disclosed |
| CN-112002712-B | Display panel, display device and manufacturing method | 武汉天马微电子有限公司 | 2022-09-16 | — | — | CN | disclosed |
| CN-114730847-A | Organic light emitting diode, method for preparing organic light emitting diode, display device and lighting device | 京东方科技集团股份有限公司 | 2022-07-08 | — | — | CN | disclosed |
| CN-110875357-B | Pixel defining structure, display panel, preparation method of display panel and display device | 京东方科技集团股份有限公司 | 2022-05-24 | — | — | CN | disclosed |
| CN-113851595-A | Organic electroluminescent device and display apparatus | 京东方科技集团股份有限公司 | 2021-12-28 | — | — | CN | disclosed |
| US-20200388773-A1 | Phenyl and Fluorenyl Substituted Phenyl-Pyrazole Complexesof Ir | UNIV SOUTHERN CALIFORNIA (US) | 2020-12-10 | — | — | US | disclosed |
| CN-112002712-A | Display panel, display device and manufacturing method | 武汉天马微电子有限公司 | 2020-11-27 | — | — | CN | disclosed |
| US-20080176102-A1 | Organic light emitting devices; electroluminescent efficiency, durability; such as tris(1-(4-biphenyl)pyrazolato)iridium complexes | THOMPSON MARK E | 2008-07-24 | — | — | US | disclosed |
| CN-100387607-C | Phenyl-pyrazole complexes of Ir | UNIV SOUTHERN CALIFORNIA (US) | 2008-05-14 | — | — | CN | disclosed |
| US-7338722-B2 | Iridium; phosphorescent, electroluminescent efficiencies in organic light emitting device; longer lifetimes, stability, efficiency in red, green and blue; one ligand has triplet energy corresponding to a wavelength 80 nm greater than wavelength corresponding to triplet energy of the other ligands; | THE UNIVERSITY OF SOUTHERN CALIFORNIA (US) | 2008-03-04 | — | — | US | disclosed |
| CN-1788012-A | Phenyl-pyrazole complexes of Ir | UNIV SOUTHERN CALIFORNIA (US) | 2006-06-14 | — | — | CN | disclosed |
| US-20060024526-A1 | tris(phenylpyrazole) iridium complex; stability | THOMPSON MARK E | 2006-02-02 | — | — | US | disclosed |
| EP-1606296-A2 | PHENYL-PYRAZOLE COMPLEXES OF Ir | UNIVERSITY OF SOUTHERN CALIFORNIA (US) | 2005-12-21 | — | — | EP | disclosed |
| US-6951694-B2 | Organic light emitting devices with electron blocking layers | THE UNIVERSITY OF SOUTHERN CALIFORNIA (US) | 2005-10-04 | — | — | US | disclosed |
| US-20040253478-A1 | Iridium; phosphorescent, electroluminescent efficiencies in organic light emitting device; longer lifetimes, stability, efficiency in red, green and blue; one ligand has triplet energy corresponding to a wavelength 80 nm greater than wavelength corresponding to triplet energy of the other ligands; | UNIVERSITY OF SOUTHERN CALIFORNIA, THE | 2004-12-16 | — | — | US | disclosed |
| WO-2004085450-A2 | PHENYL-PYRAZOLE COMPLEXES OF IR | THE UNIVERSITY OF SOUTHERN CALIFORNIA (US) | 2004-10-07 | — | — | WO | disclosed |
| US-20040048101-A1 | Organic light emitting devices with electron blocking layers | UNIVERSITY OF SOUTHERN CALIFORNIA, THE | 2004-03-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040253478-A1 | Iridium; phosphorescent, electroluminescent efficiencies in organic light emitting device; longer lifetimes, stability, efficiency in red, green and blue; one ligand has triplet energy corresponding to a wavelength 80 nm greater than wavelength corresponding to triplet energy of the other ligands; | NR2E3, IK, NR2C2 | CYP1A2 3478/4885IDO1 2261/4885METAP2 3447/4885 |
| US-20200388773-A1 | Phenyl and Fluorenyl Substituted Phenyl-Pyrazole Complexesof Ir | EML4, RCOR3, CPNE4 | CYP1A2 755/4885IDO1 2296/4885METAP2 3490/4885 |
| US-20080176102-A1 | Organic light emitting devices; electroluminescent efficiency, durability; such as tris(1-(4-biphenyl)pyrazolato)iridium complexes | EML4, RNF4, LIG4 | CYP1A2 1504/4885IDO1 2442/4885METAP2 4099/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.